American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
The American Gastroenterological Association (AGA) convened a panel of gastroenterologists expert in the area of inflammatory bowel disease (IBD) that developed this consensus statement based on expert presentations of current scientific knowledge about IBD and through subsequent group discussion. T...
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
2007
|
| _version_ | 1826267241734209536 |
|---|---|
| author | Clark, M Colombel, J Feagan, B Fedorak, R Hanauer, S Kamm, M Mayer, L Regueiro, C Rutgeerts, P Sandborn, W Sands, B Schreiber, S Targan, S Travis, S Vermeire, S |
| author_facet | Clark, M Colombel, J Feagan, B Fedorak, R Hanauer, S Kamm, M Mayer, L Regueiro, C Rutgeerts, P Sandborn, W Sands, B Schreiber, S Targan, S Travis, S Vermeire, S |
| author_sort | Clark, M |
| collection | OXFORD |
| description | The American Gastroenterological Association (AGA) convened a panel of gastroenterologists expert in the area of inflammatory bowel disease (IBD) that developed this consensus statement based on expert presentations of current scientific knowledge about IBD and through subsequent group discussion. This statement reflects the panel's assessment of medical knowledge available when written. Thus, readers should view this statement in the context of data that will accumulate after its creation. The opinions, conclusions, and recommendations expressed in this report are those of the consensus panel members and may or may not reflect the official opinion of the American Gastroenterological Association Institute. The conference upon which this report is based was funded through an unrestricted educational grant from Abbott Laboratories. Abbott Laboratories representatives did not attend the conference, nor did they participate in any way in the development of this report. |
| first_indexed | 2024-03-06T20:51:10Z |
| format | Journal article |
| id | oxford-uuid:37a138eb-c1c8-4d37-87db-84c9911df1df |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:51:10Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:37a138eb-c1c8-4d37-87db-84c9911df1df2022-03-26T13:45:10ZAmerican gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:37a138eb-c1c8-4d37-87db-84c9911df1dfEnglishSymplectic Elements at Oxford2007Clark, MColombel, JFeagan, BFedorak, RHanauer, SKamm, MMayer, LRegueiro, CRutgeerts, PSandborn, WSands, BSchreiber, STargan, STravis, SVermeire, SThe American Gastroenterological Association (AGA) convened a panel of gastroenterologists expert in the area of inflammatory bowel disease (IBD) that developed this consensus statement based on expert presentations of current scientific knowledge about IBD and through subsequent group discussion. This statement reflects the panel's assessment of medical knowledge available when written. Thus, readers should view this statement in the context of data that will accumulate after its creation. The opinions, conclusions, and recommendations expressed in this report are those of the consensus panel members and may or may not reflect the official opinion of the American Gastroenterological Association Institute. The conference upon which this report is based was funded through an unrestricted educational grant from Abbott Laboratories. Abbott Laboratories representatives did not attend the conference, nor did they participate in any way in the development of this report. |
| spellingShingle | Clark, M Colombel, J Feagan, B Fedorak, R Hanauer, S Kamm, M Mayer, L Regueiro, C Rutgeerts, P Sandborn, W Sands, B Schreiber, S Targan, S Travis, S Vermeire, S American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. |
| title | American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. |
| title_full | American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. |
| title_fullStr | American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. |
| title_full_unstemmed | American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. |
| title_short | American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. |
| title_sort | american gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease june 21 23 2006 |
| work_keys_str_mv | AT clarkm americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT colombelj americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT feaganb americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT fedorakr americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT hanauers americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT kammm americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT mayerl americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT regueiroc americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT rutgeertsp americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT sandbornw americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT sandsb americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT schreibers americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT targans americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT traviss americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 AT vermeires americangastroenterologicalassociationconsensusdevelopmentconferenceontheuseofbiologicsinthetreatmentofinflammatoryboweldiseasejune21232006 |